Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PROSCAR
- H-36731: Finasteride in Management of Elevated Red Blood Cells
- Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
- Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
- Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions
- Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions
- Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
- High Risk Prostate Cancer Prevention Study
- A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions
- A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions
- Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
- Finasteride 5 mg Tablets, Non-fasting
- Finasteride 5 mg Tablets Under Fasting Conditions
- A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart
- Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg
- Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg
- On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
- A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy
- 5-Alpha Reductase and Anabolic Effects of Testosterone
- Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
- Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)
- A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
- Medical Therapy of Prostatic Symptoms
Clinical trials list
click for details